Merck’s ‘COVID Pill’ Shows Promise, But Mortality Benefits Will Be Hard To Prove
Accurate Viral Test Shows Drug’s Promise
Executive Summary
Early results from its novel antiviral are encouraging, but demonstrating life-saving qualities in a short window of time will be tricky.